Seattle biotech Kineta will go public in deal with neurosciences company Yumanity Therapeutics by Charlotte Schubert on June 6, 2022June 7, 2022 at 11:28 am Seattle biotech company Kineta is going public through a merger with Yumanity Therapeutics, a neurosciences company based in Boston. Yumanity will also sell part of its pipeline to Johnson &… Read More